2022 BMW X4 M40i
3.0 L • 6 • 382 hp • 4×4 • AT
5UX43DT03N9L49652
Sales history: 1
• $23,500Highlights
Condition
Run and drive
Seller
Insurance • State Farm Insurance
Key included
Yes
Docs
Good
History
1 record
Drive
3.0 L • 6 • 382 hp • 4×4 • AT
Odometer
44,892 mi ≈ 72,246 km
Primary damage
Front end
Docs
TX • Cert Title
Extra
Auction
VIN
5UX43DT03N9L49652
Lot number
83940145
Copart
Sale status
Sold
Seller type
Insurance
Seller
State Farm Insurance
Location
Ft. Worth, TX
Description
Fuel type
Gasoline
Body color
Gray
Body type
SUV
Generation
G02
Trim
M40i
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular BMW models
2022 BMW X4 M40i • 3.0 L • 6 cyl • 382 hp • 4×4 • Automatic • Copart Lot: 83940145 • VIN: 5UX43DT03N9L49652
Find out more about this 2022 BMW X4 M40i, available at the Copart salvage car auction as lot 83940145 in Ft. Worth, TX. This car has Front end main damage. It is listed with Run and drive start condition code. Odometer shows 44,892 mi. This Gray BMW X4 SUV is equipped with Gasoline 3.0 L engine, 4×4 drivetrain, Automatic transmission. Check the vehicle history report for 5UX43DT03N9L49652 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
